Skip to main content
Clinical Trials/CTRI/2020/10/028581
CTRI/2020/10/028581
Not yet recruiting
未知

Inhalation Budesonide in the treatment of patients with mild Covid-19

Dr Tushar Patel0 sites0 target enrollmentTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
Health Condition 1: B972- Coronavirus as the cause of diseases classified elsewhere
Sponsor
Dr Tushar Patel
Status
Not yet recruiting
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Interventional

Investigators

Sponsor
Dr Tushar Patel

Eligibility Criteria

Inclusion Criteria

  • 1\.Patient with RT\-PCR OR Rapid Antigen confirmed diagnosis of Covid\-19\.
  • asymptomatic Patent with mild symptoms of less than 5 days duration.
  • 3\.Spo2 \>94% at room air.
  • 4\.No Radiological evidence of Pneumonia.
  • 5 Patient aged \>18years to 99Years.

Exclusion Criteria

  • 1\. Patient requiring hospitaisation.
  • 2\. Patient unable to take the drug as drirected and comply with study procedure.
  • 3\.Vulnerable population(Pregnant women,Lactating women,Prisoners,Unable to consent).
  • 4 Patients on Systemic/Inhalational Steroids.

Outcomes

Primary Outcomes

Not specified

Similar Trials